Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2006, 52, 184-189

https://doi.org/10.14712/fb2006052060184

Polymorphisms of the MDR1 Gene in the Czech Population

Kristina Pechandová, H. Buzková, O. Slanař, F. Perlík

Clinical Pharmacology Unit, Department of Pharmacology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

Received September 2006
Accepted November 2006

References

1. Bernal, M. L., Sinues, B., Fanlo, A., Mayayo, E. (2003) Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population. Ther. Drug Monit. 25, 107-111. <https://doi.org/10.1097/00007691-200302000-00016>
2. Cascorbi, I., Gerloff, T., Johne, A., Meisel, C., Hoffmeyer, S., Schwab, M., Schaeffeler, E., Eichelbaum, M., Brinkmann, U., Roots, I. (2001) Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin. Pharmacol. Ther. 69, 169-174. <https://doi.org/10.1067/mcp.2001.114164>
3. Cavaco, I., Gil, J. P., Gil-Berglund, E., Ribeiro, V. (2003) CYP3A4 and MDR1 alleles in a Portuguese population. Clin. Chem. Lab. Med. 41, 1345-1350.
4. Gaikovitch, E. A., Cascorbi, I., Mrozikiewicz, P. M., Brockmoller, J., Frotschl, R., Kopke, K., Gerloff, T., Chernov, J. N., Roots, I. (2003) Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Eur. J. Clin. Pharmacol. 59, 303-312. <https://doi.org/10.1007/s00228-003-0606-2>
5. Goreva, O. B., Grishanova, A. Y., Domnikova, N. P., Mukhin, O. V., Lyakhovich, V. V. (2004) MDR1 gene C1236T and C6+139T polymorphisms in the Russian population: associations with predisposition to lymphoproliferative diseases and drug resistance. Bull. Exp. Biol. Med. 138, 404-406. <https://doi.org/10.1007/s10517-005-0054-3>
6. Higgins, C. F., Callaghan, R., Linton, K. J., Rosenberg, M. F., Ford, R. C. (1997) Structure of the multidrug resistance P-glycoprotein. Semin. Cancer Biol. 8, 135-142. <https://doi.org/10.1006/scbi.1997.0067>
7. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., Brinkmann, U. (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA 97, 3473-3478. <https://doi.org/10.1073/pnas.97.7.3473>
8. Chowbay, B., Cumaraswamy, S., Cheung, Y. B., Zhou, Q., Lee, E. J. (2003) Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. Pharmacogenetics 13, 89-95. <https://doi.org/10.1097/00008571-200302000-00005>
9. Ishikawa, T., Hirano, H., Onishi, Y., Sakurai, A., Tarui, S. (2004) Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structureactivity relationship analyses. Drug Metab. Pharmacokinet. 19, 1-14. <https://doi.org/10.2133/dmpk.19.1>
10. Jamroziak, K., Balcerczak, E., Mlynarski, W., Mirowski, M., Robak, T. (2002) Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population. Pol. J. Pharmacol. 54, 495-500.
11. Kerb, R., Hoffmeyer, S., Brinkmann, U. (2001) ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics 2, 51-64. <https://doi.org/10.1517/14622416.2.1.51>
12. Kim, R. B., Leake, B. F., Choo, E. F., Dresser, G. K., Kubba, S. V., Schwarz, U. I., Taylor, A., Xie, H. G., McKinsey, J., Zhou, S., Lan, L. B., Schuetz, J. D., Schuetz, E. G., Wilkinson, G. R. (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther. 70, 189-199. <https://doi.org/10.1067/mcp.2001.117412>
13. Leonard, G. D., Fojo, T., Bates, S. E. (2003) The role of ABC transporters in clinical practice. Oncologist 8, 411-424. <https://doi.org/10.1634/theoncologist.8-5-411>
14. Mickley, L. A., Lee, J. S., Weng, Z., Zhan, Z., Alvarez, M., Wilson, W., Bates, S. E., Fojo, T. (1998) Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood 91, 1749-1756. <https://doi.org/10.1182/blood.V91.5.1749>
15. Rosenberg, M. F., Callaghan, R., Ford, R. C., Higgins, C. F. (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272, 10685-10694. <https://doi.org/10.1074/jbc.272.16.10685>
16. Sakaeda, T., Nakamura, T., Okumura, K. (2002) MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol. Pharm. Bull. 25, 1391-1400. <https://doi.org/10.1248/bpb.25.1391>
17. Schaeffeler, E., Eichelbaum, M., Brinkmann, U., Penger, A., Asante-Poku, S., Zanger, U. M., Schwab, M. (2001) Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 358, 383-384. <https://doi.org/10.1016/S0140-6736(01)05579-9>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive